{"pmid":32451702,"title":"Cancer survivorship care during COVID-19-perspectives and recommendations from the MASCC survivorship study group.","text":["Cancer survivorship care during COVID-19-perspectives and recommendations from the MASCC survivorship study group.","Support Care Cancer","Chan, Alexandre","Ashbury, Fred","Fitch, Margaret I","Koczwara, Bogda","Chan, Raymond Javan","32451702"],"journal":"Support Care Cancer","authors":["Chan, Alexandre","Ashbury, Fred","Fitch, Margaret I","Koczwara, Bogda","Chan, Raymond Javan"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451702","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s00520-020-05544-4","topics":["Prevention"],"weight":1,"_version_":1667881798438223872,"score":9.490897,"similar":[{"pmid":32358880,"title":"Head and neck survivorship care in the times of the SARS-CoV-2 pandemic.","text":["Head and neck survivorship care in the times of the SARS-CoV-2 pandemic.","With the arrival of the coronavirus disease (SARS-CoV-2) in the United States, care practice paradigms have drastically changed. Data from China suggest that the new virus poses additional risks as case fatality of patients with cancer was higher at 5.6% compared to 2.3% of the general population. There are three proposed major strategies to address care for patients with cancer in this SARS-CoV-2 pandemic with postponing treatment for those with stable cancer, increasing personal protection provisions for patients with cancer, and increasing monitoring if a patient becomes infected with SARS-CoV-2. In this present commentary, we discuss the unique mental health challenges and burdens of patients with head and neck cancer in the times of the SARS-CoV-2 pandemic and approaches to mitigate these stressors through telemedicine to reduce future burdens to the patient and the health care system.","Head Neck","Huang, Victoria W","Imam, Sarah A","Nguyen, Shaun A","32358880"],"abstract":["With the arrival of the coronavirus disease (SARS-CoV-2) in the United States, care practice paradigms have drastically changed. Data from China suggest that the new virus poses additional risks as case fatality of patients with cancer was higher at 5.6% compared to 2.3% of the general population. There are three proposed major strategies to address care for patients with cancer in this SARS-CoV-2 pandemic with postponing treatment for those with stable cancer, increasing personal protection provisions for patients with cancer, and increasing monitoring if a patient becomes infected with SARS-CoV-2. In this present commentary, we discuss the unique mental health challenges and burdens of patients with head and neck cancer in the times of the SARS-CoV-2 pandemic and approaches to mitigate these stressors through telemedicine to reduce future burdens to the patient and the health care system."],"journal":"Head Neck","authors":["Huang, Victoria W","Imam, Sarah A","Nguyen, Shaun A"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32358880","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/hed.26235","keywords":["corona","covid","head and neck cancer","survival","virus"],"locations":["United States","China"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138495347851264,"score":93.98821},{"pmid":32420631,"title":"Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic.","text":["Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic.","The 2019 Coronavirus Pandemic challenges the delivery of care for patients with head and neck cancer. An important aspect of this care has been the evolution of enhanced survivorship services, which include surveillance for recurring cancer and prevention of second primaries. The application of evidence-based approaches to the identification and management of treatment and tumor-related toxicities has embraced the use of validated patient-reported outcomes instruments, health promotion, and care coordination. In this manuscript, we describe how our multidisciplinary team of survivorship providers has accommodated to the need to provide patients with social distancing while acknowledging the importance of continued care during treatment and through the spectrum of survivorship.","Head Neck","Nilsen, Marci Lee","Clump, David A 2nd","Kubik, Mark","Losego, Karen","Mrozek, Alyssa","Pawlowicz, Elizabeth","Pickford, Debra","Sridharan, Shaum","Traylor, Katie","Wasserman-Wincko, Tamara","Young, Kelly","Zandberg, Dan","Johnson, Jonas T","32420631"],"abstract":["The 2019 Coronavirus Pandemic challenges the delivery of care for patients with head and neck cancer. An important aspect of this care has been the evolution of enhanced survivorship services, which include surveillance for recurring cancer and prevention of second primaries. The application of evidence-based approaches to the identification and management of treatment and tumor-related toxicities has embraced the use of validated patient-reported outcomes instruments, health promotion, and care coordination. In this manuscript, we describe how our multidisciplinary team of survivorship providers has accommodated to the need to provide patients with social distancing while acknowledging the importance of continued care during treatment and through the spectrum of survivorship."],"journal":"Head Neck","authors":["Nilsen, Marci Lee","Clump, David A 2nd","Kubik, Mark","Losego, Karen","Mrozek, Alyssa","Pawlowicz, Elizabeth","Pickford, Debra","Sridharan, Shaum","Traylor, Katie","Wasserman-Wincko, Tamara","Young, Kelly","Zandberg, Dan","Johnson, Jonas T"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420631","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/hed.26256","keywords":["covid-19","cancer","coronavirus","head and neck","survivorship","treatment effects"],"topics":["Prevention"],"weight":1,"_version_":1667159284505378818,"score":90.18475},{"pmid":32456845,"title":"Effectiveness of Clinical Examination in Cancer Surveillance: New Paradigm to Cancer Survivorship Beyond the COVID-19 Pandemic.","text":["Effectiveness of Clinical Examination in Cancer Surveillance: New Paradigm to Cancer Survivorship Beyond the COVID-19 Pandemic.","Clin Oncol (R Coll Radiol)","Boon, I S","Au Yong, T P T","Boon, C S","32456845"],"journal":"Clin Oncol (R Coll Radiol)","authors":["Boon, I S","Au Yong, T P T","Boon, C S"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32456845","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.clon.2020.05.011","topics":["Prevention"],"weight":1,"_version_":1667967698907168768,"score":87.92349}]}